FDA Investigator Susan M Corrales
Susan M Corrales has inspections in 1 countries as of 10 May 2023. Susan M Corrales has collaborated with a combinined 993 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
10 May 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Ademola O Daramola,
Albert A Salvador,
Ana Delp Cintron,
Ana P Barido,
Angela E Glenn,
Barbara T Carmichael,
CDR Ileana Barreto Pettit,
CDR Sean T Creighton,
Chiaochun J Wang,
Chyla T Hunter,
Colleen M Aspinwall,
Courtney A Gilbert,
Courtney A Hunt,
Craig A Garmendia,
Dandan Wang, PhD,
Dawn M Mccabe,
Dianiris C Ayala,
Dyvette Arline,
Ethan P Stegman,
Fabian Nchaparro Rodriguez,
Frank Schwingen,
Ivan E Reyes,
Jana L Caylor,
Jennifer D Hollstrom,
Jennifer L Huntington,
Jennifer M Menendez,
Jessica L Pressley,
Joanne E King,
Jogy George,
Jolanna A Norton,
Jude C Dikes,
LCDR Michael H Tollon,
Libia M Lugo,
Linda K Matheny,
LT Tamara J Henderson,
Marc Balzarini,
Maria V Price,
Michelle S Dunaway,
Miguel A Martinez,
Paul A Licata,
Rachel A Peters,
Rebecca Rodriguez,
Richard K Vogel,
Robert D Tollefsen,
Ronnie E Jackson,
Roy R Rinc,
Sarah E Mcmullen,
Sherbet L Samuels,
Siramad Sainz Trujillo,
State Agency,
Stephanie D Crockett,
Susan M Turcovski,
Thomas J Arista,
Valerie J Grecek Trinh
Susan M Corrales's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2001 | FDA 483 Response | Trividia Health, Inc. - Form 483R, 2001-11-05 |
January, 2001 | EIR | Salon Sciences Corporation - EIR, 2001-01-31 |
October, 2003 | EIR | Microstim Technology, Inc. - EIR, 2003-10-31 |
April, 2003 | EIR | Barry Baumel, M.D. - EIR, 2003-04-29 |
March, 2002 | EIR | Actavis Laboratories FL, Inc. - EIR, 2002-03-01 |
October, 2001 | EIR | Trividia Health, Inc. - EIR, 2001-10-19 |
April, 2003 | FDA 483 | Barry Baumel, M.D. - Form 483, 2003-04-29 |
January, 2001 | FDA 483 | Salon Sciences Corporation - Form 483, 2001-01-31 |
March, 2003 | FDA 483 | OneBlood, Inc. - Form 483, 2003-03-14 |
January, 2004 | FDA 483 Response | Garden of Life, Inc - Form 483R, 2004-06-03 |
January, 2004 | EIR | Garden of Life, Inc - EIR, 2004-01-23 |
October, 2001 | FDA 483 | Trividia Health, Inc. - Form 483, 2001-10-19 |
March, 2002 | FDA 483 | Actavis Laboratories FL, Inc. - Form 483, 2002-03-01 |
October, 2002 | FDA 483 | Nutraceutical Evolution, Inc. - Form 483, 2002-10-23 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more